Author:
Malekinejad Hassan,Rokhsartalab-Azar Shirin,Hassani-Dizaj Sepideh,Alizadeh-Fanalou Shahin,Rezabakhsh Aysa,Amniattalab Amir
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference22 articles.
1. Barakat L, Jayyousi A, Bener A, Zuby B, Zirie M (2013) Comparison of efficacy and safety of rosuvastatin, atorvastatin and pravastatin among dyslipidemic diabetic patients. ISRN Pharmacol 2013:146579. doi: 10.1155/2013/146579
2. Dixit N, Baboota S, Kohli K, Ahmad S, Ali J (2007) Silymarin: a review of pharmacological aspects and bioavailability enhancement approaches. Indian J Pharmacol 39:172–179
3. Green LC, Wagner AD, Glogowski J et al (1982) Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 126:131–138
4. Jacobsen W, Kuhn B, Soldner A, Kirchner G, Sewing K-F, Kollman P, Benet LZ, Christian U (2000) Lactonization is the critical first step in the disposition of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor atorvastatin. Drug Metab Dispos 28:1369–1378
5. Katnapally PK, Janaki A, Anreddy RNR, Yellu NR (2009) Pharmacokinetics and pharmacodynamics of atorvastatin alone and in combination with lercanidipine in hyperlipidemic rats. J Pharm Res 2:66–70
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献